Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2025 | Faeth Therapeutics | $25.0M Series A | S2G | F-Prime Capital Partners, Future Ventures, General Catalyst, Khosla Ventures, Matthew McAviney, OrbiMed, Avicella Capital, B Capital Group, Cantos, Digitalis Ventures, KdT Ventures |